In Republic of South Africa the trials of a new vaccine against human immunodeficiency virus have started

The trials of the vaccine NVTN 702 gathered nearly 5.4 thousand citizens of Republic of South Africa in the age from eighteen to thirty-five years. The trial will have been continuing approximately four years, and the results of the experiment will have been represented by 2020.

The authorities of Republic of South Africa report that now in the country nearly one thousand people catch this illness daily, and in 2014 nearly 2.4 million people got the infection of this disease.

In 2009, in Thailand the clinical investigations of the vaccine against human immunodeficiency virus during 3.5 years had been holding. Then it was proved that its efficiency comprised 31.2 per cent.

The first of December is known as the International Day of fighting with AID. As it is reported by the International Organization of Health Care, human immunodeficiency virus is one of the main global problems.

Currently it took lives of more than 35 millions of human lives. In 2015 more than one million of people died because of the illnesses connected to human immunodeficiency virus all over the world.

In 2015 in the world approximately 37 million of people with human immunodeficiency virus infection have been counted. The more affected region is Africa to the South from Sahara.